住院帕金森病专属项目对用药错误的影响
本研究评估了针对住院帕金森病患者的专属住院项目对用药错误率和出院结局的影响。项目于2023年实施并优化,包括电子健康记录普查、运动障碍专科高级执业人员监测与方案对齐、定制警报与左旋多巴医嘱、药师支持及员工教育。比较2024年1-6月与2018年实施前回顾队列,发现用药错误多项指标和出院至非家庭环境比例显著降低。
要点
- 专属住院项目可减少禁忌药物剂量、左旋多巴剂量偏差、剂型替换、时间偏差和漏服。
- 项目实施后出院至非家庭环境比例从44.8%降至38.3%。
- 多学科主动管理模式有望改善住院帕金森病患者用药安全与出院结局。
核心结论
- 实施多学科主动住院项目后,住院帕金森病患者的用药错误减少且出院结局改善。
研究设计与样本
- 2024年1-6月实施后监测366例次住院,与2018年实施前回顾队列比较用药错误率和临床结局。
主要发现
- 接受禁忌药物者中位剂量数从2(IQR 1-6)降至1(IQR 1-2),p=0.015。
- 左旋多巴剂量偏差天数从43.1%降至38.3%,p<0.0001。
- 不当左旋多巴剂型替换从18.6%降至5%,p<0.0001。
- 给药时间偏差从72.2%降至51.8%,p<0.00001;漏服从21.5%降至16.8%,p=0.013。
- 出院至非家庭环境比例从44.8%降至38.3%,p=0.038。
临床怎么用
- 可参考该模式整合电子病历普查、专科人员监测、定制医嘱警报、药师支持和员工教育以减少用药错误。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hospitalized people with Parkinson's disease (PwP) face increased risks of medication errors and discharge to non-home settings, both of which are associated with adverse outcomes. This study assessed differences in medication error rates and discharge outcomes before and after implementation of a dedicated inpatient program for hospitalized PwP. METHODS: During 2023, a Parkinson's disease (PD) inpatient program was implemented and refined combining: (1) an electronic health record (EHR) census for identification of hospitalized PwP; (2) inpatient monitoring and alignment of inpatient and outpatient regimens by movement-disorders-trained advanced practitioners; (3) customized EHR alerts and levodopa orders; (4) pharmacist support, and (5) staff education. Medication error rates and clinical outcomes were compared between January and June 2024 (post-implementation phase) and a pre-implementation retrospective cohort from 2018. RESULTS: From January to June 2024, 366 post-implementation admissions were monitored. Among those receiving contraindicated medications, the median number of doses decreased from 2 (interquartile range [IQR] = 1-6) during pre-implementation to 1 (IQR: 1-2) post-implementation (p = 0.015). Days with a levodopa dose deviation decreased from 43.1% to 38.3%, p < 0.0001, improper levodopa formulation substitutions from 18.6% to 5%, p < 0.0001, timing deviations from 72.2% to 51.8%, p < 0.00001, missed doses from 21.5% to 16.8%, p = 0.013, and discharged to non-home settings from 44.8% to 38.3%, p = 0.038. INTERPRETATION: Following implementation of a multidisciplinary and proactive inpatient program, reductions in medication errors and improved discharge outcomes were observed among PwP. ANN NEUROL 2026;100:1068-1079.
引用
- Piccinin CC, Yu JRT, Stepanyants V, et al. Effects of an Inpatient Program on Medication Errors in Hospitalized People with Parkinson's Disease. Ann Neurol. 2026. PMID: 42671071. doi:10.1002/ana.78345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。